The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Xylosylated naphthoic acid-amino acid conjugates for investigation of glycosaminoglycan priming.

Author

Summary, in English

Three different series of xylosylated naphthoic acid-amino acid conjugates containing one or two amino acid residues were synthesized for the investigation of glycosaminoglycan priming and potential use as anti-tumor drugs. All xylosylated naphthoic acid-conjugates inhibited the growth of normal lung fibroblasts to some extent, whereas the growth of tumor derived T24 carcinoma cells was not affected. There was no correlation between amino acid conjugation, retention time and the antiproliferative activity. Only one compound initiated the priming of glycosaminoglycans. Modification of the naphthalene ring with one or two amino acid residues did not have any effect on proteoglycan biosynthesis or glycosaminoglycan priming in T24 carcinoma cells.

Publishing year

2008

Language

English

Pages

1473-1477

Publication/Series

Carbohydrate Research

Volume

343

Issue

9

Document type

Journal article

Publisher

Elsevier

Topic

  • Basic Medicine

Status

Published

Research group

  • Glycobiology

ISBN/ISSN/Other

  • ISSN: 1873-426X